Managing diabetes in dialysis patients

被引:21
作者
O'Toole, Sam M. [2 ]
Fan, Stanley L. [1 ]
Yaqoob, M. Magdi [1 ]
Chowdhury, Tahseen A. [2 ]
机构
[1] Barts & London Queen Marys Sch Med & Dent, Dept Nephrol, London, England
[2] Barts & London Queen Marys Sch Med & Dent, Dept Diabet & Metab, London, England
关键词
STAGE RENAL-DISEASE; QUALITY-OF-LIFE; PREDIALYSIS GLYCEMIC CONTROL; GLUCOSE MONITORING-SYSTEM; LONG-TERM PROGNOSIS; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR EVENTS; REPLACEMENT THERAPY; RISK-FACTORS; MORTALITY;
D O I
10.1136/postgradmedj-2011-130354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Burgeoning levels of diabetes are a major concern for dialysis services, as diabetes is now the most common cause of end-stage renal disease in most developed nations. With the rapid rise in diabetes prevalence in developing countries, the burden of end stage renal failure due to diabetes is also expected to rise in such countries. Diabetic patients on dialysis have a high burden of morbidity and mortality, particularly from cardiovascular disease, and a higher societal and economic cost compared to non-diabetic subjects on dialysis. Tight glycaemic and blood pressure control in diabetic patients has an important impact in reducing risk of progression to end stage renal disease. The evidence for improving glycaemic control in patients on dialysis having an impact on mortality or morbidity is sparse. Indeed, many factors make improving glycaemic control in patients on dialysis very challenging, including therapeutic difficulties with hypoglycaemic agents, monitoring difficulties, dialysis strategies that exacerbate hyperglycaemia or hypoglycaemia, and possibly a degree of therapeutic nihilism or inertia on the part of clinical diabetologists and nephrologists. Standard drug therapy for hyperglycaemia (eg, metformin) is clearly not possible in patients on dialysis. Thus, sulphonylureas and insulin have been the mainstay of treatment. Newer therapies for hyperglycaemia, such as gliptins and glucagon-like peptide-1 analogues have become available, but until recently, renal failure has precluded their use. Newer gliptins, however, are now licensed for use in 'severe renal failure', although they have yet to be trialled in dialysis patients. Diabetic patients on dialysis have special needs, as they have a much greater burden of complications (cardiac, retinal and foot). They may be best managed in a multidisciplinary diabetic-renal clinic setting, using the skills of diabetologists, nephrologists, clinical nurse specialists in nephrology and diabetes, along with dietitians and podiatrists.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 74 条
[1]  
Abbott KC, 2001, CLIN NEPHROL, V56, P124
[2]   Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis [J].
Abe, Masanori ;
Okada, Kazuyoshi ;
Maruyama, Takashi ;
Maruyama, Noriaki ;
Matsumoto, Koichi .
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (02) :169-176
[3]   Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions [J].
Abularrage, Christopher J. ;
Conrad, Mark F. ;
Hackney, Lauren A. ;
Paruchuri, Vikram ;
Crawford, Robert S. ;
Kwolek, Christopher J. ;
LaMuraglia, Glenn M. ;
Cambria, Richard P. .
JOURNAL OF VASCULAR SURGERY, 2010, 52 (02) :314-322
[4]   Health-related quality of life in patients with type 1 diabetes-association with diabetic complications (the FinDiane Study) [J].
Ahola, Aila J. ;
Saraheimo, Markku ;
Forsblom, Carol ;
Hietala, Kustaa ;
Sintonen, Harri ;
Groop, Per-Henrik .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (06) :1903-1908
[5]  
[Anonymous], NAT SERV FRAM REN SE
[6]  
[Anonymous], 2008, NICE GUIDELINE CG66
[7]   The cost of renal dialysis in a UK setting - a multicentre study [J].
Baboolal, Keshwar ;
McEwan, Philip ;
Sondhi, Seema ;
Spiewanowski, Piotr ;
Wechowski, Jaroslaw ;
Wilson, Karen .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (06) :1982-1989
[8]  
Chung SH, 2008, PERITON DIALYSIS INT, V29, pS132
[9]   The Burden of Amputation Among Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) [J].
Combe, Christian ;
Albert, Justin M. ;
Bragg-Gresham, Jennifer L. ;
Andreucci, Vittorio E. ;
Disney, Alex ;
Fukuhara, Shunichi ;
Goodkin, David A. ;
Gillespie, Brenda W. ;
Saito, Akira ;
Jadoul, Michel ;
Pisoni, Ronald L. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (04) :680-692
[10]   Blood pressure control and symptomatic intradialytic hypotension in diabetic haemodialysis patients: A cross-sectional survey [J].
Davenport, Andrew ;
Cox, Claire ;
Thuraisingham, Raj .
NEPHRON CLINICAL PRACTICE, 2008, 109 (02) :C65-C71